Centessa Pharmaceuticals (CNTA) Insider Trading & Ownership $22.02 +0.21 (+0.96%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$22.24 +0.22 (+0.99%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.09%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$5.87MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$17.26M Get CNTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Centessa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CNTA Insider Buying and Selling by Quarter Centessa Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/15/2025Iqbal J HussainGeneral CounselSell6,000$21.85$131,100.00 9/10/2025Tia L BushCTOSell25,000$22.00$550,000.00 9/9/2025Iqbal J HussainGeneral CounselSell20,000$20.01$400,200.00 9/9/2025Mario Alberto AccardiInsiderSell7,000$20.00$140,000.00 9/9/2025Tia L BushCTOSell24,792$20.00$495,840.00 8/15/2025Iqbal J HussainGeneral CounselSell6,000$17.23$103,380.00 7/29/2025Mario Alberto AccardiInsiderSell8,322$15.23$126,744.06 7/25/2025Gregory M WeinhoffInsiderSell10,000$15.56$155,600.00 7/21/2025Saurabh SahaCEOSell55,000$15.92$875,600.00 6/25/2025Gregory M WeinhoffInsiderSell10,000$13.86$138,600.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/24/2025Iqbal J HussainGeneral CounselSell12,000$14.02$168,240.00 6/24/2025Mario Alberto AccardiInsiderSell15,000$14.00$210,000.00 6/20/2025Saurabh SahaCEOSell55,000$12.63$694,650.00 5/27/2025Gregory M WeinhoffInsiderSell10,000$12.82$128,200.00 5/20/2025Saurabh SahaCEOSell55,000$12.71$699,050.00 5/16/2025Arjun GoyalDirectorBuy417,646$12.73$5,316,633.58 5/15/2025Arjun GoyalDirectorBuy44,939$12.24$550,053.36 5/1/2025Iqbal J HussainGeneral CounselSell311$14.00$4,354.00 4/28/2025Iqbal J HussainGeneral CounselSell2,080$14.01$29,140.80 4/25/2025Gregory M WeinhoffInsiderSell11,742$13.61$159,808.62 4/25/2025Iqbal J HussainGeneral CounselSell3,609$14.00$50,526.00 4/21/2025Saurabh SahaCEOSell14,656$12.29$180,122.24 3/25/2025Gregory M WeinhoffInsiderSell10,000$16.34$163,400.00 3/20/2025Saurabh SahaCEOSell55,000$16.69$917,950.00 3/17/2025David M ChaoInsiderSell7,000$17.17$120,190.00 3/17/2025Iqbal J HussainGeneral CounselSell6,000$16.45$98,700.00 2/20/2025Saurabh SahaCEOSell55,000$15.93$876,150.00 2/18/2025Iqbal J HussainGeneral CounselSell6,000$16.18$97,080.00 2/10/2025Karen M AndersonInsiderSell429$18.99$8,146.71 2/7/2025Karen M AndersonInsiderSell30,526$19.03$580,909.78 2/3/2025Karen M AndersonInsiderSell6,471$16.86$109,101.06 2/3/2025Tia L BushCTOSell11,000$16.86$185,460.00 1/27/2025Gregory M WeinhoffInsiderSell11,742$16.47$193,390.74 1/21/2025Saurabh SahaCEOSell55,000$15.77$867,350.00 1/15/2025Iqbal J HussainGeneral CounselSell6,000$15.29$91,740.00 12/26/2024Gregory M WeinhoffInsiderSell10,000$17.04$170,400.00 12/20/2024Saurabh SahaCEOSell55,000$17.44$959,200.00 12/17/2024Karen M AndersonInsiderSell10,624$17.32$184,007.68 12/17/2024Tia L BushCTOSell17,813$18.00$320,634.00 12/16/2024Iqbal J HussainGeneral CounselSell77,705$16.39$1,273,584.95 12/13/2024Karen M AndersonInsiderSell5,876$17.01$99,950.76 12/6/2024Saurabh SahaCEOSell87,496$18.46$1,615,176.16 11/25/2024Gregory M WeinhoffInsiderSell10,000$17.66$176,600.00 11/25/2024Saurabh SahaCEOSell299$18.23$5,450.77 11/22/2024Saurabh SahaCEOSell1,671$18.24$30,479.04 11/20/2024Saurabh SahaCEOSell55,000$16.89$928,950.00 10/25/2024Gregory M WeinhoffInsiderSell11,742$15.38$180,591.96 10/23/2024Saurabh SahaCEOSell2,592$15.32$39,709.44 10/21/2024Saurabh SahaCEOSell22,205$15.80$350,839.00 9/25/2024Gregory M WeinhoffInsiderSell16,619$15.69$260,752.11 9/20/2024Saurabh SahaCEOSell55,000$16.53$909,150.00 (Data available from 1/1/2013 forward) CNTA Insider Trading Activity - Frequently Asked Questions Who is on Centessa Pharmaceuticals' Insider Roster? The list of insiders at Centessa Pharmaceuticals includes Antoine Yver, Arjun Goyal, David M Chao, Gregory M Weinhoff, Harris Rotman, Iqbal J Hussain, Karen M Anderson, Mario Alberto Accardi, Saurabh Saha, Thomas Templeman, and Tia L Bush. Learn more on insiders at CNTA. What percentage of Centessa Pharmaceuticals stock is owned by insiders? 7.09% of Centessa Pharmaceuticals stock is owned by insiders. Learn more on CNTA's insider holdings. Which Centessa Pharmaceuticals insiders have been buying company stock? The following insider purchased CNTA shares in the last 24 months: Arjun Goyal ($5,866,686.94). How much insider buying is happening at Centessa Pharmaceuticals? Insiders have purchased a total of 462,585 CNTA shares in the last 24 months for a total of $5,866,686.94 bought. Which Centessa Pharmaceuticals insiders have been selling company stock? The following insiders have sold CNTA shares in the last 24 months: David M Chao ($120,190.00), Gregory M Weinhoff ($2,250,793.09), Harris Rotman ($270,337.06), Iqbal J Hussain ($2,448,045.75), Karen M Anderson ($1,589,896.79), Mario Alberto Accardi ($476,744.06), Saurabh Saha ($12,898,377.11), and Tia L Bush ($1,551,934.00). How much insider selling is happening at Centessa Pharmaceuticals? Insiders have sold a total of 1,361,106 Centessa Pharmaceuticals shares in the last 24 months for a total of $21,606,317.86 sold. Centessa Pharmaceuticals Key ExecutivesDr. Saurabh Saha M.D. (Age 48)Ph.D., CEO & Director Compensation: $1.04MDr. David M. Chao Ph.D. (Age 56)Chief Administrative Officer Compensation: $710.3kMr. John J. Crowley CPA (Age 50)CFO and Principal Financial & Accounting Officer Ms. Tia L. Bush (Age 53)Chief Technology & Quality Officer 2 recent tradesMs. Kristen K. Sheppard Esq.J.D., Senior Vice President of Investor Relations & Corporate CommunicationsMr. Iqbal J. Hussain L.L.B. (Age 43)General Counsel, Chief Compliance Officer & Corporate Secretary 8 recent tradesMs. Karen M. Anderson (Age 56)Chief People Officer Dr. Gregory M. Weinhoff M.B.A. (Age 53)M.D., Chief Business Officer Compensation: $655kDr. Mario Alberto Accardi Ph.D.President of the Orexin Program3 recent tradesMs. April DovholukSenior Vice President of Development Operations More Insider Trading Tools from MarketBeat Related Companies Revolution Medicines Insider Transactions Grifols Insider Transactions Rhythm Pharmaceuticals Insider Transactions Avidity Biosciences Insider Transactions Cytokinetics Insider Transactions Axsome Therapeutics Insider Transactions Nuvalent Insider Transactions TG Therapeutics Insider Transactions Merus Insider Transactions CRISPR Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NASDAQ:CNTA) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
